195 related articles for article (PubMed ID: 32282710)
1. Prognostic role of galectins expression in patients with hepatic cancer: A meta-analysis.
Shao Q; He J; Chen Z; Wu C
Medicine (Baltimore); 2020 Apr; 99(15):e19622. PubMed ID: 32282710
[TBL] [Abstract][Full Text] [Related]
2. Association between high galectin expression and poor prognosis in hematologic cancers: a systematic review and meta-analysis.
Liu H; Dai Q; Li Y; Tang Z; She T
Hematology; 2023 Dec; 28(1):2227494. PubMed ID: 37343172
[TBL] [Abstract][Full Text] [Related]
3. Prognostic and diagnostic significance of galectins in pancreatic cancer: a systematic review and meta-analysis.
Sun Q; Zhang Y; Liu M; Ye Z; Yu X; Xu X; Qin Y
Cancer Cell Int; 2019; 19():309. PubMed ID: 31832021
[TBL] [Abstract][Full Text] [Related]
4. Clinical characteristics and prognostic significance of galectins for patients with gastric cancer: A meta-analysis.
Long B; Yu Z; Zhou H; Ma Z; Ren Y; Zhan H; Li L; Cao H; Jiao Z
Int J Surg; 2018 Aug; 56():242-249. PubMed ID: 29940258
[TBL] [Abstract][Full Text] [Related]
5. Prognostic Value of Galectin Expression in Patients with Breast Cancer: Systematic Review and Meta-Analysis.
Ramos-Martínez JC; Altamirano-Gómez G; Ramos-Martínez I; Valencia J; Hernández-Zimbrón L; Hernández-Juárez J; Echeverría-Vásquez P; Hernández-González LL; Pérez-Campos E; Pérez-Campos Mayoral L; Ramos-Martínez E
Clin Breast Cancer; 2022 Jul; 22(5):399-409. PubMed ID: 35058144
[TBL] [Abstract][Full Text] [Related]
6. Circulating levels of PD-L1 and Galectin-9 are associated with patient survival in surgically treated Hepatocellular Carcinoma independent of their intra-tumoral expression levels.
Sideras K; de Man RA; Harrington SM; Polak WG; Zhou G; Schutz HM; Pedroza-Gonzalez A; Biermann K; Mancham S; Hansen BE; Bart Takkenberg R; van Vuuren AJ; Pan Q; Ijzermans JNM; Sleijfer S; Sprengers D; Dong H; Kwekkeboom J; Bruno MJ
Sci Rep; 2019 Jul; 9(1):10677. PubMed ID: 31337865
[TBL] [Abstract][Full Text] [Related]
7. Prognostic role of galectin-3 expression in patients with solid tumors: a meta-analysis of 36 eligible studies.
Wang Y; Liu S; Tian Y; Wang Y; Zhang Q; Zhou X; Meng X; Song N
Cancer Cell Int; 2018; 18():172. PubMed ID: 30410421
[TBL] [Abstract][Full Text] [Related]
8. Galectin-9 acts as a prognostic factor with antimetastatic potential in hepatocellular carcinoma.
Zhang ZY; Dong JH; Chen YW; Wang XQ; Li CH; Wang J; Wang GQ; Li HL; Wang XD
Asian Pac J Cancer Prev; 2012; 13(6):2503-9. PubMed ID: 22938412
[TBL] [Abstract][Full Text] [Related]
9. Prognostic Significance of Pretreatment Apolipoprotein A-I as a Noninvasive Biomarker in Cancer Survivors: A Meta-Analysis.
Zhang Y; Yang X
Dis Markers; 2018; 2018():1034037. PubMed ID: 30510601
[TBL] [Abstract][Full Text] [Related]
10. The Prognostic Significance of NEK2 in Hepatocellular Carcinoma: Evidence from a Meta-Analysis and Retrospective Cohort Study.
Cheng Y; Chen X; Ye L; Zhang Y; Liang J; Liu W; Zhou B; Zheng S; Huang Y; Chen G; Deng Y; Zhang Q; Yang Y
Cell Physiol Biochem; 2018; 51(6):2746-2759. PubMed ID: 30562736
[TBL] [Abstract][Full Text] [Related]
11. [Expression and prognostic value of galectin-9 in hepatocellular carcinoma patients].
Gu CJ; Wu H; Sheng CY; Ni QC
Zhonghua Yi Xue Za Zhi; 2013 Jul; 93(26):2025-8. PubMed ID: 24169278
[TBL] [Abstract][Full Text] [Related]
12. Galectins-1, -3, -7, -8 and -9 as prognostic markers for survival in epithelial ovarian cancer: A systematic review and meta-analysis.
Pergialiotis V; Papoutsi E; Androutsou A; Tzortzis AS; Frountzas M; Papapanagiotou A; Kontzoglou K
Int J Gynaecol Obstet; 2021 Mar; 152(3):299-307. PubMed ID: 33156523
[TBL] [Abstract][Full Text] [Related]
13. Prognostic and Clinical Significance of Aspartate Aminotransferase-to-Lymphocyte Ratio Index in Individuals with Liver Cancer: A Meta-Analysis.
Peng X; Huang Y; Zhang M; Chen Y; Zhang L; He A; Luo R
Dis Markers; 2022; 2022():3533714. PubMed ID: 35186165
[TBL] [Abstract][Full Text] [Related]
14. Prognostic Role of Glasgow Prognostic Score in Patients With Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis.
Li MX; Bi XY; Li ZY; Huang Z; Han Y; Zhou JG; Zhao JJ; Zhang YF; Zhao H; Cai JQ
Medicine (Baltimore); 2015 Dec; 94(49):e2133. PubMed ID: 26656342
[TBL] [Abstract][Full Text] [Related]
15. Galectin-9 Expression Predicts Favorable Clinical Outcome in Solid Tumors: A Systematic Review and Meta-Analysis.
Zhou X; Sun L; Jing D; Xu G; Zhang J; Lin L; Zhao J; Yao Z; Lin H
Front Physiol; 2018; 9():452. PubMed ID: 29765332
[No Abstract] [Full Text] [Related]
16. Prognostic value of cytokeratin 19 in hepatocellular carcinoma: A meta-analysis.
Sun DW; Zhang YY; Sun XD; Chen YG; Qiu W; Ji M; Lv GY
Clin Chim Acta; 2015 Aug; 448():161-9. PubMed ID: 26164382
[TBL] [Abstract][Full Text] [Related]
17. Transarterial chemoembolization versus hepatic resection in hepatocellular carcinoma treatment: a meta-analysis.
Tian X; Dai Y; Wang DQ; Zhang L; Sui CG; Meng FD; Jiang SY; Liu YP; Jiang YH
Drug Des Devel Ther; 2015; 9():4431-40. PubMed ID: 26309396
[TBL] [Abstract][Full Text] [Related]
18. Prognostic values of microRNA-130 family expression in patients with cancer: a meta-analysis and database test.
Peng Z; Duan F; Yin J; Feng Y; Yang Z; Shang J
J Transl Med; 2019 Oct; 17(1):347. PubMed ID: 31640738
[TBL] [Abstract][Full Text] [Related]
19. Metallothioneins may be a potential prognostic biomarker for tumors: A Prisma-compliant meta-analysis.
Wang L; Xin F; Lin N; Wang Y; Liu X; Liu J
Medicine (Baltimore); 2018 Dec; 97(52):e13786. PubMed ID: 30593161
[TBL] [Abstract][Full Text] [Related]
20. Hierarchical and selective roles of galectins in hepatocarcinogenesis, liver fibrosis and inflammation of hepatocellular carcinoma.
Bacigalupo ML; Manzi M; Rabinovich GA; Troncoso MF
World J Gastroenterol; 2013 Dec; 19(47):8831-49. PubMed ID: 24379606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]